Choate Secures Patent Victory for TYMLOS® Portfolio
Choate secured a victory for Radius Health, Inc. (“Radius”) and Ipsen Pharma S.A.S. (“Ipsen”) in a Hatch-Waxman litigation against Orbicular Pharmaceutical Technologies Private Ltd. (“Orbicular”) relating to Orbicular’s proposed generic for TYMLOS® (abaloparatide), indicated for the treatment of osteoporosis.